JP2023548083A5 - - Google Patents
Info
- Publication number
- JP2023548083A5 JP2023548083A5 JP2023525049A JP2023525049A JP2023548083A5 JP 2023548083 A5 JP2023548083 A5 JP 2023548083A5 JP 2023525049 A JP2023525049 A JP 2023525049A JP 2023525049 A JP2023525049 A JP 2023525049A JP 2023548083 A5 JP2023548083 A5 JP 2023548083A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- polypeptide
- acid sequence
- sequence
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063108163P | 2020-10-30 | 2020-10-30 | |
| US63/108,163 | 2020-10-30 | ||
| PCT/US2021/057197 WO2022094177A1 (en) | 2020-10-30 | 2021-10-29 | Compositions and methods for treating celiac sprue disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548083A JP2023548083A (ja) | 2023-11-15 |
| JP2023548083A5 true JP2023548083A5 (cg-RX-API-DMAC7.html) | 2024-11-06 |
Family
ID=78819631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525049A Pending JP2023548083A (ja) | 2020-10-30 | 2021-10-29 | セリアックスプルー病を治療するための組成物及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250064903A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4237554A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023548083A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230093323A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116829166A (cg-RX-API-DMAC7.html) |
| AR (1) | AR123961A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021368118A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3195929A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2023006731A2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023004807A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202233834A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022094177A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025068987A1 (en) | 2023-09-28 | 2025-04-03 | Takeda Pharmaceutical Company Limited | A method of producing a kumamolisin-as polypeptide |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE440857T1 (de) * | 1998-10-05 | 2009-09-15 | Takeda Pharmaceutical | Verfahren zum eliminieren von n-terminalem methionin |
| JP4475707B2 (ja) * | 1998-10-05 | 2010-06-09 | 武田薬品工業株式会社 | N末端メチオニンの除去方法 |
| LT2718434T (lt) | 2011-08-10 | 2018-08-10 | University Of Washington Through Its Center For Commercialization | Kompozicijos ir būdai, skirti celiakijos gydymui |
| US10266815B2 (en) * | 2013-08-14 | 2019-04-23 | University Of Washington Through Its Center For Commercialization | Compositions and methods for treating celiac sprue disease |
| ES2883347T3 (es) * | 2014-06-16 | 2021-12-07 | Codexis Inc | Composiciones y procedimientos para atenuar y prevenir la inflamación intestinal debida a la presencia de antígenos alimentarios peptídicos en un intestino |
| TN2017000520A1 (en) * | 2015-06-08 | 2019-04-12 | Univ California | Compositions and methods for treating celiac sprue disease |
| MX2019007287A (es) * | 2016-12-22 | 2019-09-27 | Ew Nutrition Gmbh | Variantes de proteasas estables. |
-
2021
- 2021-10-29 US US18/034,622 patent/US20250064903A1/en active Pending
- 2021-10-29 WO PCT/US2021/057197 patent/WO2022094177A1/en not_active Ceased
- 2021-10-29 MX MX2023004807A patent/MX2023004807A/es unknown
- 2021-10-29 AU AU2021368118A patent/AU2021368118A1/en not_active Abandoned
- 2021-10-29 CA CA3195929A patent/CA3195929A1/en active Pending
- 2021-10-29 EP EP21816227.9A patent/EP4237554A1/en not_active Withdrawn
- 2021-10-29 TW TW110140404A patent/TW202233834A/zh unknown
- 2021-10-29 CN CN202180068658.4A patent/CN116829166A/zh active Pending
- 2021-10-29 AR ARP210103015A patent/AR123961A1/es not_active Application Discontinuation
- 2021-10-29 JP JP2023525049A patent/JP2023548083A/ja active Pending
- 2021-10-29 KR KR1020237017895A patent/KR20230093323A/ko not_active Withdrawn
-
2023
- 2023-05-24 CO CONC2023/0006731A patent/CO2023006731A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025028857A5 (cg-RX-API-DMAC7.html) | ||
| Kiyatkin et al. | Cloning and structure of cDNA encoding α‐latrotoxin from black widow spider venom | |
| Sacco et al. | The primary structure of the cytotoxin alpha-sarcin. | |
| JP2643968B2 (ja) | Kex2エンドプロテアーゼ及びその製造方法 | |
| JP2023518596A5 (cg-RX-API-DMAC7.html) | ||
| IL273439B1 (en) | Fusion proteins comprising enzyme replacement therapy enzymes | |
| KR890003802A (ko) | 재조합 dna 기술에 의해 제조된 소의 췌장 트립신 억제제, 그 제조 방법, 발현 벡터 및 재조합 숙주 및 그의 제약적 용도 | |
| HUT73394A (en) | Process for production of protein | |
| CN104507489A (zh) | 用于预防和治疗类风湿性关节炎的组合物 | |
| JP2015504052A5 (cg-RX-API-DMAC7.html) | ||
| JP2024532503A5 (cg-RX-API-DMAC7.html) | ||
| Harumiya et al. | EBP-37, a new elastin-binding protein in human plasma: structural similarity to ficolins, transforming growth factor-β1-binding proteins | |
| FI4034555T3 (fi) | Dap10/dap12-fuusiopolypeptidit | |
| CN105829350A (zh) | 肠激酶可切割的多肽 | |
| WO2022241831A1 (zh) | 多肽的制备方法 | |
| JP2024038140A5 (cg-RX-API-DMAC7.html) | ||
| CA2076320A1 (en) | Process for producing peptide | |
| JP2015510770A5 (cg-RX-API-DMAC7.html) | ||
| Ishizaki et al. | Production of recombinant human glucagon in the form of a fusion protein in Escherichia coli; recovery of glucagon by sequence-specific digestion | |
| AU2013234860B2 (en) | Method of producing a recombinant peptide | |
| JP2021514194A (ja) | ブタトリプシンの変異体 | |
| WO2025179727A1 (zh) | 沃索利肽可溶性中间体、中间体制备方法及沃索利肽的制备方法 | |
| KR102174197B1 (ko) | 생산성이 향상된 비독성 프로테아제 | |
| Greenwood et al. | Purification and processing of cellulose‐binding domain‐alkaline phosphatase fusion proteins | |
| WO2025179726A1 (zh) | 利那洛肽可溶性中间体和利那洛肽的制备方法 |